fbpx

Logo

COVID-19 News
Navigation

Factors Driving Expanded Use of Tissue Plasminogen Activator for Acute Ischemic Stroke

By | on April 12, 2016 | 0 Comment

Factors Driving Expanded Use of Tissue Plasminogen Activator for Acute Ischemic Stroke

Factors Driving Expanded Use of Tissue Plasminogen Activator for Acute Ischemic Stroke

Current Issue

ACEP Now: Vol 44 – No 01 – January 2025

Download PDF

Read More

About the Author

Joseph Harrington

View this author's posts »

No Responses to “Factors Driving Expanded Use of Tissue Plasminogen Activator for Acute Ischemic Stroke”

Leave a Reply

Your email address will not be published. Required fields are marked *


*


Current Issue

ACEP Now: Vol 44 – No 01 – January 2025

Download PDF

Read More

Wiley
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603